Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10710870rdf:typepubmed:Citationlld:pubmed
pubmed-article:10710870lifeskim:mentionsumls-concept:C0010416lld:lifeskim
pubmed-article:10710870lifeskim:mentionsumls-concept:C0003308lld:lifeskim
pubmed-article:10710870lifeskim:mentionsumls-concept:C0033734lld:lifeskim
pubmed-article:10710870lifeskim:mentionsumls-concept:C0013162lld:lifeskim
pubmed-article:10710870pubmed:issue1lld:pubmed
pubmed-article:10710870pubmed:dateCreated2000-4-4lld:pubmed
pubmed-article:10710870pubmed:abstractTextSeventy-one isolates of Cryptococcus neoformans and 5 isolates of Prototheca spp. were tested for in vitro susceptibility against amphotericin B alone and against the combination of amphotericin B with each clinically relevant concentration of flucytosine (5-FC) and rifampin by broth dilution methods. The combinations of amphotericin B and rifampin produced greater effect on reduction of the minimal inhibition concentration (MIC) of amphotericin B than did either drug used individually. Flucytosine combined with amphotericin B produced little or no reduction of the MIC compared with amphotericin B alone.lld:pubmed
pubmed-article:10710870pubmed:languageenglld:pubmed
pubmed-article:10710870pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10710870pubmed:citationSubsetIMlld:pubmed
pubmed-article:10710870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10710870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10710870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10710870pubmed:statusMEDLINElld:pubmed
pubmed-article:10710870pubmed:monthJanlld:pubmed
pubmed-article:10710870pubmed:issn0125-2208lld:pubmed
pubmed-article:10710870pubmed:authorpubmed-author:Tanphaichitra...lld:pubmed
pubmed-article:10710870pubmed:authorpubmed-author:ChaiprasertAAlld:pubmed
pubmed-article:10710870pubmed:authorpubmed-author:SrimuangSSlld:pubmed
pubmed-article:10710870pubmed:authorpubmed-author:Prariyachatig...lld:pubmed
pubmed-article:10710870pubmed:authorpubmed-author:Rungsipanurat...lld:pubmed
pubmed-article:10710870pubmed:issnTypePrintlld:pubmed
pubmed-article:10710870pubmed:volume83lld:pubmed
pubmed-article:10710870pubmed:ownerNLMlld:pubmed
pubmed-article:10710870pubmed:authorsCompleteYlld:pubmed
pubmed-article:10710870pubmed:pagination57-60lld:pubmed
pubmed-article:10710870pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:10710870pubmed:meshHeadingpubmed-meshheading:10710870...lld:pubmed
pubmed-article:10710870pubmed:meshHeadingpubmed-meshheading:10710870...lld:pubmed
pubmed-article:10710870pubmed:meshHeadingpubmed-meshheading:10710870...lld:pubmed
pubmed-article:10710870pubmed:meshHeadingpubmed-meshheading:10710870...lld:pubmed
pubmed-article:10710870pubmed:meshHeadingpubmed-meshheading:10710870...lld:pubmed
pubmed-article:10710870pubmed:meshHeadingpubmed-meshheading:10710870...lld:pubmed
pubmed-article:10710870pubmed:meshHeadingpubmed-meshheading:10710870...lld:pubmed
pubmed-article:10710870pubmed:meshHeadingpubmed-meshheading:10710870...lld:pubmed
pubmed-article:10710870pubmed:meshHeadingpubmed-meshheading:10710870...lld:pubmed
pubmed-article:10710870pubmed:year2000lld:pubmed
pubmed-article:10710870pubmed:articleTitleAntifungal drug combinations for Cryptococcus neoformans and Prototheca spp.lld:pubmed
pubmed-article:10710870pubmed:affiliationResearch Center, Faculty of Medicine, Ramathibodi Hospital, Bangkok, Thailand.lld:pubmed
pubmed-article:10710870pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10710870pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:10710870pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed